The Lancet: March 25, 2008
Josef Smolen from the Medical University of Vienna, Austria, discusses in this week's podcast how the monoclonal antibody tocilizumab could be effective in treating rheumatoid arthritis. Tocilizumab blocks interleukin 6, a pro-inflammatory cytokine involved in the biological process behind rheumatoid arthritis (Source: Listen to The Lancet)
Source: Listen to The Lancet - March 25, 2008 Category: Journals (General) Authors: The Lancet Source Type: podcasts

ASFH Uveitis Associated with Juvenile Idiopathic Arthritis
Guest: Jennifer E. Thorne, M.D.Associate Professor of Ophthalmology Division of Ocular ImmunologyThe Wilmer Eye InstituteBaltimore, MD (Source: As Seen From Here)
Source: As Seen From Here - April 15, 2007 Category: Opthalmology Authors: JYoungMD at Source Type: podcasts